We are excited to announce our minority investment in Function Health, a personalized lab testing startup that is transforming the preventative healthcare landscape.
Our investment comes as part of a significant funding round led by Redpoint Ventures and other strategic investors. The startup offers comprehensive lab testing services designed to detect early biomarkers of disease, perfectly aligning with our vision of supporting innovative companies that are reshaping industries.
Launched in 2023, Function previously raised $53 million after a funding round last year led by venture firm Andreessen Horowitz, with participation from a number of celebrities.
“At Next Sparc, we’ve always been passionate about health and wellness, but we’re seeing an unprecedented wave of technological innovation that’s changing how we approach personal healthcare,” said Len Pagon, Jr., founder of Next Sparc. “Our investment in Function Health represents more than a financial commitment—it’s a strategic partnership that embodies our belief in proactive, personalized solutions that can meaningfully improve people’s lives.”
Founded by Dr. Mark Hyman, a recognized Functional Medicine leader and advocate, Function Health provides annual membership packages that include advanced diagnostic testing. The startup has gained significant attention in the longevity tech sector.
This investment marks a notable shift in our own investment strategy, increasing our focus on minority stakes in high-potential, innovative companies. By leveraging our operational expertise and founder-friendly approach, we aim to support Function Health’s continued growth and impact in the preventative healthcare space.
This approach will allow us to further diversify our portfolio, support cutting-edge innovation, and maintain our core commitment to founder-driven success.
To learn more about Function Health and its vision, visit functionhealth.com.